Complete Genomics | GenomeWeb

Complete Genomics

BGISEQ-50

The new BGISEQ-50, a smaller version of the BGISEQ-500, will have research and clinical applications, and BGI plans to register it with the CFDA, too.

The PGP team used Complete Genomics' Long-Fragment Read technology to analyze the set of samples.

Last year, Radboud University Medical Centre's genetics lab conducted about 6,000 diagnostic exome tests and ran 2,000 nex-gen sequencing-based BRCA1/2 hereditary cancer assays.

Genos Research, a Complete Genomics spinoff, plans to build a large database of individuals with sequenced exomes and genomes, allowing them to license their data to researchers. 

Mao Mao

Mao Mao joined BGI Genomics in February from WuXi AppTec, where he was responsible for in vitro diagnostics product development and clinical lab services.

Genome sequences for 600 disease-free individuals over 80 years old suggest protective variants related to cognition may mitigate disease and boost healthspan.

The study sequenced the genomes of 300 deceased patients and found many variants consistent with diseases and adverse drug events the patients encountered during their lives.

Pacific Biosciences' launch of the Sequel instrument, Oxford Nanopore Technologies' MinIon instrument, and 10X Genomics' technology excited the market in 2015.

Using genome, exome, and other data, researchers provide evidence for a Fanconi anemia subtype characterized by de novo, dominant negative mutations in RAD51.

The company plans to lay off 145 employees at its Mountain View headquarters, as well as 15 in San Jose, 13 in Sunnyvale, and six in San Francisco.

Pages

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.